Friday, November 20, 2026
SearchAdmin

The Intelligent Ledger

AI-Curated Financial Intelligence

Back to headlines

AI-Powered Throat Scanner Revolutionizes Influenza Diagnosis

|Original source
AI-Powered Throat Scanner Revolutionizes Influenza Diagnosis

+AI Analysis - Key Points

  • 01

    Nodoca uses AI to analyze images of the pharynx and patient data to provide an influenza assessment

  • 02

    The device eliminates the need for a nasal swab test, reducing discomfort and allowing for earlier diagnosis

  • 03

    Nodoca has been approved in Japan and has been introduced at over 2,000 medical institutions

The process of examining a patient's throat has remained largely unchanged since ancient times. However, the patterns of findings that appear in the throat can differ depending on the pathogen, and a significant amount of information lies hidden there. A Japanese company called Iris, led by Sho Okuyama, is seeking to unlock that information using artificial intelligence.

The system developed by Iris, Nodoca, uses AI to analyze images of the pharynx captured with a compact camera-equipped device, together with information from the patient's medical interview and other data, and returns an influenza assessment in a little over 10 seconds. It eliminates the need for the conventional test—one that is prone to causing discomfort because it requires inserting a swab deep into the nose to collect a nasal specimen—and can also be used at an earlier stage after symptom onset.

Article illustration
Related coverage

In 2022, it became the first AI-equipped medical device in Japan to receive approval as a “new medical device” and gain coverage under the national health insurance system. It has since been introduced at more than 2,000 medical institutions across Japan. In October 2025, it also received approval for an additional function related to Covid-19.

Okuyama is a former emergency physician who also has experience practicing medicine on remote islands. On an island with only a few hundred residents, the only medical equipment available was essentially a stethoscope, and he says he had to rely on his own eyes and ears to treat patients.

“When people hear ‘medical AI,’ they tend to think of the part that makes diagnoses,” Okuyama says. “But the real differentiating factor lies in sensing—how the data is acquired. We developed our own hardware and ventured into the area of pharyngeal images, which no one had touched.”

When the company was founded in 2017, there was no training data for AI focused on the throat. Okuyama therefore lent dedicated cameras to around 100 medical institutions and, over the course of about three years, collected data with patients’ consent. By overcoming three major uncertainties—the development of the hardware, the collection of training data, and whether AI-assisted diagnosis could truly be made to work—the company opened the path to practical implementation.

Once Nodoca had been commercialized, its accuracy improved significantly, and it has since become a valuable tool for medical professionals in Japan. The device's ability to provide quick and accurate diagnoses has the potential to revolutionize the way we approach influenza diagnosis and treatment.

The success of Nodoca is a testament to the power of innovation and collaboration in the medical field. By working together, researchers and developers can create solutions that improve patient outcomes and transform the way we practice medicine.

VideoVideo Coverage

AI-Powered Throat Scanner Revolutionizes Influenza Diagnosis

Watch video coverage on YouTube

Opens relevant video results on YouTube.